GE MEDICAL SYSTEMS

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

Phase 3
Completed
Conditions
Normal Pressure Hydrocephalus
Interventions
Drug: [18F] Flutemetamol
First Posted Date
2010-01-21
Last Posted Date
2012-06-11
Lead Sponsor
GE Healthcare
Target Recruit Count
7
Registration Number
NCT01053312
Locations
🇺🇸

GE Healthcare, Princeton, New Jersey, United States

Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease

First Posted Date
2009-12-09
Last Posted Date
2014-09-11
Lead Sponsor
GE Healthcare
Target Recruit Count
365
Registration Number
NCT01028053
Locations
🇺🇸

GE Healthcare, Princeton, New Jersey, United States

Prevalence of Sleep Disordered Breathing

First Posted Date
2009-11-11
Last Posted Date
2012-01-05
Lead Sponsor
GE Healthcare
Target Recruit Count
53
Registration Number
NCT01011647
Locations
🇺🇸

Ohio State University Medical Center, Columbus, Ohio, United States

Radiant Warmer Trial

Not Applicable
Withdrawn
Conditions
Body Temperature Changes
Interventions
Device: GEHC IWS 4400 & Giraffe warmer beds
First Posted Date
2009-11-11
Last Posted Date
2015-09-14
Lead Sponsor
GE Healthcare
Registration Number
NCT01011855

Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)

First Posted Date
2009-10-30
Last Posted Date
2012-04-05
Lead Sponsor
GE Healthcare
Target Recruit Count
50
Registration Number
NCT01004770
Locations
🇺🇸

GE Healthcare, Princeton, New Jersey, United States

Trial of Yellow Fever Inactivated Vaccine

First Posted Date
2009-10-15
Last Posted Date
2016-05-05
Lead Sponsor
GE Healthcare
Target Recruit Count
60
Registration Number
NCT00995865
Locations
🇺🇸

Johnson County Clin-Trials, Lenexa, Kansas, United States

Technical Validation of Lunar iDXA (GE Healthcare) Visceral Fat Tool

Completed
Conditions
Obesity
Interventions
Device: Visceral fat mass measurement
First Posted Date
2009-09-30
Last Posted Date
2010-12-08
Lead Sponsor
GE Healthcare
Target Recruit Count
124
Registration Number
NCT00987298
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

First Posted Date
2009-06-11
Last Posted Date
2014-06-09
Lead Sponsor
GE Healthcare
Target Recruit Count
70
Registration Number
NCT00918281
Locations
🇺🇸

101 Carnegie Center, Princeton, New Jersey, United States

Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)

Phase 4
Completed
Conditions
Renal Insufficiency
Chronic Kidney Disease
Interventions
Drug: Omniscan
First Posted Date
2009-05-25
Last Posted Date
2014-07-17
Lead Sponsor
GE Healthcare
Target Recruit Count
213
Registration Number
NCT00908310
Locations
🇺🇸

GE Healthcare, Princeton, New Jersey, United States

Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).

First Posted Date
2009-04-09
Last Posted Date
2012-08-24
Lead Sponsor
GE Healthcare
Target Recruit Count
30
Registration Number
NCT00878878
Locations
🇺🇸

ICON Development Solutions, Elliott City, Maryland, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy